ORAGENICS INC
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. PROPERTIES
We leased approximately 2,207 square feet for our corporate offices located at 4902 Eisenhower Boulevard, Suite 125, Tampa, Florida 33634. Lease payments per month are inclusive of insurance, taxes and utilities. The lease expired on February 28, 2024, as we elected not to renew it.
In addition to our Tampa location, we leased space at 13700 Progress Boulevard, Alachua, Florida 32615, the space was used as our research facility where some of the research and development for our lantibiotics program was completed. The facility was approximately 5,300 square feet of which approximately 60% was used for laboratory space and the remainder was used as office space and common areas. In September of 2023, we terminated the lease for the Alachua facility. Lease costs for the Alachua facility for the year ended December 31, 2023, include insurance, taxes, utilities, and a one-time early termination fee of approximately $162,000.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.